Modeling Progression in Type II Diabetes using Causal Machine Learning

Results of GNS Healthcare and Pfizer published in Journal of Diabetes Science and Technology (JDST)

Traditional analytical approaches to matching interventions to patients are time-consuming and limited in their capabilities. Often healthcare companies ask what they could be doing to provide better care. Using the power of of shared data and causal machine learning, value-based solutions are now available from GNS Healthcare, paving the way for more effective treatments for patients and the discovery of new therapies and cures.

GNS  is leading the way, partnering with major names in the healthcare industry to provide value-based solutions such as:

  • Subpopulation Analysis
  • Disease Mechanisms of Action
  • Target Discovery
  • Value-based Drug Models
  • Intervention Optimization